Bioventus
BVS
156 hedge funds and large institutions have $509M invested in Bioventus in 2026 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 75 increasing their positions, 38 reducing their positions, and 23 closing their positions.
350% more call options, than puts
Call options by funds: $2.21M | Put options by funds: $491K
97% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 38
9% more capital invested
Capital invested by funds: $466M → $509M (+$43M)
3.69% more ownership
Funds ownership: 75.79% → 79.48% (+3.7%)
9% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 23
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
1% less funds holding
Funds holding: 157 → 156 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
American Century Companies
Kansas City,
Missouri
|
+$7M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$5.67M |
| 3 |
ECM
Engine Capital Management
New York
|
+$5.59M |
| 4 |
BlackRock
New York
|
+$2.89M |
| 5 |
RA
Royce & Associates
New York
|
+$2.79M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$5.51M |
| 2 |
D.E. Shaw & Co
New York
|
-$2.51M |
| 3 |
SEI Investments
Oaks,
Pennsylvania
|
-$2.33M |
| 4 |
MIM
Meros Investment Management
Dallas,
Texas
|
-$1.9M |
| 5 |
LCM
Legato Capital Management
San Francisco,
California
|
-$1.75M |
BVS Hedge Fund Activity: Q2 2026 in Review
156 of the 8,349 institutional investors tracked by Wall St. Rank reported a position in Bioventus (BVS) for Q2 2026, worth a combined $509M — up 9.2% from $466M a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new BVS positions and 23 closed out — a net gain of 2 holders — while 75 added to existing stakes and 38 trimmed.
The largest buyer was American Century Companies, adding an estimated $7M. The largest seller was Essex Investment Management, exiting entirely with an estimated $5.51M sold.
- 156 institutional investors held Bioventus (BVS) as of Q2 2026, down from 157 in Q1 2026.
- Funds reported $509M of Bioventus stock for Q2 2026, up 9.2% quarter-over-quarter.
- 25 funds opened new Bioventus positions in Q2 2026 and 23 closed out, a net change of +2 holders.
- The largest Bioventus buyer in Q2 2026 was American Century Companies, an estimated $7M added.
- The largest Bioventus seller in Q2 2026 was Essex Investment Management, an estimated $5.51M sold.
Based on aggregated 13F filings for Q2 2026.